Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash used in operating activities | (163,694) | (107,686) |
| Cash flows from investing activities: | ||
| Capitalized internal-use software costs | (773) | — |
| Purchases of property and equipment | (307) | (56) |
| Purchases of marketable securities | (564,050) | (158,404) |
| Maturities of marketable securities | 231,837 | 125,290 |
| Net cash used in investing activities | (333,293) | (33,170) |
| Cash flows from financing activities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s capex?
- Praxis Precision Medicines, Inc. (PRAX) reported capex of $245K in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s capex changed year-over-year?
- Praxis Precision Medicines, Inc.'s capex increased by 337.5% year-over-year, from $56K to $245K.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s capex?
- Over 3 years (2021 to 2024), Praxis Precision Medicines, Inc.'s capex has grown at a -100.0% compound annual growth rate (CAGR), from $1.05M to $0.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Praxis Precision Medicines, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude